PMC:7784828 / 963-1603 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T17","span":{"begin":0,"end":15},"obj":"Sentence"},{"id":"T18","span":{"begin":16,"end":153},"obj":"Sentence"},{"id":"T19","span":{"begin":154,"end":373},"obj":"Sentence"},{"id":"T20","span":{"begin":374,"end":479},"obj":"Sentence"},{"id":"T21","span":{"begin":480,"end":640},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Expert opinion: The massive challenges encountered during drug development urgently call for a serious global rethinking of the way this process is done. A partial solution might be if many consortiums of multi-nations, academic institutions, clinicians, pharma companies, and funding agencies gather at different fronts to crowdsource resources, share knowledge and risks. Such an ecosystem can rapidly generate first-in-class molecules that are safe, effective, and affordable. We think that this article represents a wake-up call for the scientific community to immediately reassess the current drug discovery and development procedures."}